Skip to main content

Evaluating mHealth technology in HIV to improve Empowerment and healthcare utilisation: Research and innovation to Generate Evidence for personalised care

Objective

EmERGE will develop a mHealth platform to enable self-management of HIV in patients with stable disease. The platform will build upon and integrate the existing mHealth solutions operated by pioneering healthcare providers in the UK and Spain and apply a rigorous co-design approach to ensure patient and clinician input to the solution. The platform will provide users with web based and mobile device applications which interface securely with relevant medical data and facilitate remote access to key healthcare providers EATG, the European HIV patient organisation, will provide a direct and deep interaction with representative patients and clinicians from 5 EU countries. The platform and interfaces will be validated in a large study of 3900 patients using a tailored HTA process, MAST, specifically developed for the assessment of mHealth solutions including translatability as a key factor. Based on prior work showing a high uptake rate and use of mHealth in HIV patient populations, EmERGE aims to demonstrate the benefits to patients and simultaneous increases in cost-effectiveness for healthcare providers by reducing face-to-face consultations, estimated at 6000 saved per year within this study alone. Patient reported outcomes will be agreed and used in the assessment and development of the system which also aims to increase adherence and enable frailty to be reported using mHealth technology. Innovation will be given priority from the beginning by developing new business models of care provision, targeting key stakeholders in the EU health provider sector, including policymakers and clinicians, while eliciting demand from patients to highlight and initiate the widespread implementation and compensation of mHealth solutions within the timeframe of the project. Guidelines and policy briefs will be produced to evidence the benefits and disseminate the lessons learned to support the uptake of mHealth for self-management of other chronic diseases.

Field of science

  • /social sciences/economics and business/business and management/business model
  • /social sciences/economics and business

Call for proposal

H2020-PHC-2014-single-stage
See other projects for this call

Funding Scheme

RIA - Research and Innovation action

Coordinator

BRIGHTON AND SUSSEX UNIVERSITY HOSPITALS NHS TRUST
Address
Royal Sussex County Hospital, Eastern Road
BN2 5BE Brighton
United Kingdom
Activity type
Research Organisations
EU contribution
€ 870 877,95

Participants (14)

EUROPEAN AIDS TREATMENT GROUP EV
Germany
EU contribution
€ 483 429
Address
Mettmanner Strasse 24-26
40233 Dusseldorf
Activity type
Other
UNIVERSITY OF BRIGHTON
United Kingdom
EU contribution
€ 573 170,91
Address
Lewes Road Mithras House
BN2 4AT Brighton
Activity type
Higher or Secondary Education Establishments
PRINS LEOPOLD INSTITUUT VOOR TROPISCHE GENEESKUNDE
Belgium
EU contribution
€ 413 552,43
Address
Nationalestraat 155
2000 Antwerpen
Activity type
Higher or Secondary Education Establishments
PODMEDICS LIMITED

Participation ended

United Kingdom
EU contribution
€ 198 473,34
Address
8 Copse Wood Way
HA6 2UE Northwood
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
FUNDACIO CLINIC PER A LA RECERCA BIOMEDICA
Spain
EU contribution
€ 724 755,52
Address
Carrer Rossello 149
08036 Barcelona
Activity type
Research Organisations
THE UNIVERSITY OF SUSSEX
United Kingdom
EU contribution
€ 82 774,72
Address
Sussex House Falmer
BN1 9RH Brighton
Activity type
Higher or Secondary Education Establishments
CENTRO HOSPITALAR DE LISBOA CENTRAL, EPE
Portugal
EU contribution
€ 338 062,24
Address
Rua Jose Antonio Serrano
1169 097 Lisboa
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
KLINIKA ZA INFEKTIVNE BOLESTI DR. FRAN MIHALJEVIC
Croatia
EU contribution
€ 310 142,88
Address
Mirogojska Cesta 8
10000 Zagreb
Activity type
Research Organisations
NPMS-HHC CIC
United Kingdom
EU contribution
€ 466 425
Address
21 Bedford Square
WC1B 3HH London
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
UNIVERSIDAD POLITECNICA DE MADRID
Spain
EU contribution
€ 403 518,75
Address
Calle Ramiro De Maeztu 7 Edificio Rectorado
28040 Madrid
Activity type
Higher or Secondary Education Establishments
MHEALTH FUTURES LTD

Participation ended

United Kingdom
EU contribution
€ 69 421,99
Address
19 New Road
BN1 1UF Brighton
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
KITE INNOVATION (EUROPE) LIMITED

Participation ended

United Kingdom
EU contribution
€ 118 600,83
Address
3M Buckley Innovation Centre
HD1 3BD Huddersfield
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
MODUS RESEARCH AND INNOVATION LIMITED
United Kingdom
EU contribution
€ 191 405,23
Address
7-11 Melville Street
EH3 7PE Edinburgh
Activity type
Research Organisations
EMERGE MHEALTH LTD
United Kingdom
EU contribution
€ 212 869,35
Address
18 Hyde Gardens
BN21 4PT Eastbourne East Sussex
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)